You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Litigation Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC

Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)

Date Filed Document No. Description Snippet Link To Document
2022-11-04 142 Decision C.A. No. 22-2159 (D.D.C.) Distribution System and Method, U.S. Patent No. 8,731,963 (“the ‘963 Patent”). Jazz’s oxybate drugs are distributed…2) a “Patent Statement,” which represents that no existing patents listed in the FDA’s patent database…existing patent or why the existing patent is invalid. Id. § 355(b)(2)(A)(i)–(iv). 3 A Patent Certification…submitting a Patent Statement. On May 24, 2022, the FDA rejected Avadel’s Patent Statement. It…claimed by an existing method-of-use patent held by Jazz (the “Patent Decision”). On June 6, 2022, Avadel External link to document
2022-11-18 146 Memorandum Opinion alleges infringement of U.S. Patent Nos. 8,731,963 ("the '963 patent"), 10,758,488 ("…quot;the ' 488 patent"), 10,813 ,885 ("the ' 885 patent"), 10,959,956 ("…quot;the ' 956 patent"), 10,966,931 ("the ' 931 patent"), 11 ,077,079 ("the…the ' 079 patent"), and 11,147,782 ("the '782 patent"). 1 Before the Court is…quot; It is a bedrock principle of patent law that the claims of a patent define the invention to which External link to document
2022-11-18 147 Order following claim terms of U.S. Patent Nos. 8,731 ,963 ("the ' 963 patent"), 10,758,488 ("…formulation that is not ('488 patent; ' 885 patent; ' 956 patent; ' 931 …quot;the ' 488 patent"), 10,813 ,885 ("the ' 885 patent"), 10,959,956 ("the…;the ' 956 patent"), 10,966,931 ("the ' 931 patent"), 11 ,077,079 ("the…the ' 079 patent"), and 11 ,147,782 ("the '782 patent") as follows: External link to document
2022-12-27 166 Letter discovery deadlines related to U.S. Patent No. 8,731,963 (“the ʼ963 patent”) while this Court’s Order and … seven patents-in-suit from three different patent families. The ʼ963 patent is the only patent asserted…infringement or validity of the ʼ963 patent from either a patent or regulatory law perspective. …expected to opine on the ʼ963 patent is expected to opine on the formulation patents. Therefore, staying discovery…related to the ’963 patent, including the regulatory exclusivity relating to that patent, but regardless External link to document
2023-01-18 177 Notice of Service Kevin C. Almeroth Regarding Patent Ineligibility of U.S. Patent No. 8,731,963, (3) Opening Expert Report…Kevin C. Almeroth Regarding Patent Ineligibility of U.S. Patent No. 8,731,963, (3) Opening Expert Report…Jeffrey Gudin Regarding Invalidity of U.S. Patent 8,731,963, (9) Expert Report of Dr. Martin Scharf, and…Jeffrey Gudin Regarding Invalidity of U.S. Patent 8,731,963, (9) Expert Report of Dr. Martin Scharf, …10 November 2021 1:21-cv-01594 830 Patent Both District Court, D. Delaware External link to document
2023-03-09 189 Exs. 1-12 . 6,514,531, issued February 4, 2003 (“Alaux 2003”); 2. U.S. Patent No. 5,594,030, issued… the ’963 patent (“REMS Patent”), and for the ’488 patent, the ’885 patent, the ’956 patent, and the … the ’963 patent, the ’488 patent, the ’885 patent, the ’956 patent, and the ’931 patent. In those…refers to the ’488 patent, the ’885 patent, the ’956 patent, and the ’931 patent as the “Sustained Release…Standard for the ’488 patent, the ’885 patent, the ’956 patent, and the ’931 patent. In those Initial External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.